tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Income Statement

Compare
263 Followers

Gain Therapeutics Income Statement

Last quarter (Q3 2024), Gain Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Gain Therapeutics's net income was $-4.49M. See Gain Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 55.18K$ 140.11K$ 164.99K$ 28.88K
Gross Profit
$ 0.00$ -25.20K$ 75.94K$ -7.00M$ -2.23M
Operating Expenses
$ 20.35M$ 22.31M$ 17.92M$ 13.99M$ 3.51M
Depreciation and Amortization
$ 0.00$ 83.58K$ 64.17K$ 15.48K$ 9.59K
EBITDA
$ -20.35M$ -22.17M$ -17.78M$ -13.82M$ -3.47M
Operating Income
$ -20.35M$ -22.25M$ -17.78M$ -13.83M$ -3.48M
Other Income/Expenses
$ 476.22K$ 64.89K$ 279.28K$ -60.42K$ -92.85K
Pretax Income
$ -19.87M$ -22.19M$ -17.50M$ -13.89M$ -3.57M
Net Income
$ -20.41M$ -22.27M$ -17.59M$ -13.89M$ -3.58M
Per Share Metrics
Basic EPS
$ -0.89$ -1.71$ -1.48$ -1.37$ -0.30
Diluted EPS
$ -0.89$ -1.71$ -1.48$ -1.37$ -0.30
Weighted Average Shares Outstanding
22.88M 13.01M 11.88M 10.17M 11.88M
Weighted Average Shares Outstanding (Diluted)
22.88M 13.01M 11.88M 10.17M 11.88M
Currency in USD

Gain Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis